Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Mancuso

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Plos One|October 12, 2018
Human and entomologic investigations of chikungunya outbreak in Mandera, Northeastern Kenya, 2016Samson Limbaso Konongoi, Albert Nyunja, Victor Ofula, et al.
Cancer Research|February 20, 2016
In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast TumorsZhen Zhao, Xiaoping Zhu, Kemi Cui, et al.
Bioinformatics (Oxford, England)|February 16, 2019
Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination predictionLei Huang, David Brunell, Clifford Stephan, et al.
Military Medicine|March 25, 2020
HIV Care Continuum and Meeting 90-90-90 Targets: Cascade of Care Analyses of a U.S. Military CohortAndrew Anglemyer, Noah Haber, Adi Noiman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 29, 2017
Subarachnoid hemorrhage - Induced block of cerebrospinal fluid flow: Role of brain coagulation factor III (tissue factor)Eugene V Golanov, Evgeniy I Bovshik, Kelvin K Wong, et al.
American Heart Journal|October 6, 2018
Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)Christopher P Cannon, Darren K McGuire, Richard Pratley, et al.
Circulation|October 7, 2020
Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV TrialFrancesco Cosentino, Christopher P Cannon, David Z I Cherney, et al.
Expert Opinion on Investigational Drugs|July 23, 2019
A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric RecommendationsHani M Babiker, Lisa Davis, Kristian Larson, et al.
The New England Journal of Medicine|September 23, 2020
Cardiovascular Outcomes with Ertugliflozin in Type 2 DiabetesChristopher P Cannon, Richard Pratley, Samuel Dagogo-Jack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2007
An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in IraqPaul Scott, Gregory Deye, Arjun Srinivasan, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Plos One|October 12, 2018
Human and entomologic investigations of chikungunya outbreak in Mandera, Northeastern Kenya, 2016Samson Limbaso Konongoi, Albert Nyunja, Victor Ofula, et al.
Cancer Research|February 20, 2016
In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast TumorsZhen Zhao, Xiaoping Zhu, Kemi Cui, et al.
Bioinformatics (Oxford, England)|February 16, 2019
Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination predictionLei Huang, David Brunell, Clifford Stephan, et al.
Military Medicine|March 25, 2020
HIV Care Continuum and Meeting 90-90-90 Targets: Cascade of Care Analyses of a U.S. Military CohortAndrew Anglemyer, Noah Haber, Adi Noiman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 29, 2017
Subarachnoid hemorrhage - Induced block of cerebrospinal fluid flow: Role of brain coagulation factor III (tissue factor)Eugene V Golanov, Evgeniy I Bovshik, Kelvin K Wong, et al.
American Heart Journal|October 6, 2018
Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)Christopher P Cannon, Darren K McGuire, Richard Pratley, et al.
Circulation|October 7, 2020
Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV TrialFrancesco Cosentino, Christopher P Cannon, David Z I Cherney, et al.
Expert Opinion on Investigational Drugs|July 23, 2019
A Multidisciplinary Evaluation of Barriers to Enrolling Cancer Patients into Early Phase Clinical Trials: Challenges and Patient-centric RecommendationsHani M Babiker, Lisa Davis, Kristian Larson, et al.
The New England Journal of Medicine|September 23, 2020
Cardiovascular Outcomes with Ertugliflozin in Type 2 DiabetesChristopher P Cannon, Richard Pratley, Samuel Dagogo-Jack, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2007
An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in IraqPaul Scott, Gregory Deye, Arjun Srinivasan, et al.
Pageof 3